APOG surges on $1.3B deal
Apogee Therapeutics shares rise after securing a $1.3 billion financing partnership with Blackstone, boosting the company's growth prospects. The deal is expected to support APOG's development pipeline.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.